BRUTAFLAM 90

About

Brutaflam 90 contains Etoricoxib, a highly selective cyclooxygenase-2 (COX-2) inhibitor, belonging to the class of non-steroidal anti-inflammatory drugs (NSAIDs). It works by specifically blocking the COX-2 enzyme, which is responsible for the synthesis of prostaglandins, key mediators of pain, inflammation, and fever. By selectively inhibiting COX-2, Etoricoxib aims to reduce these symptoms while potentially minimizing the gastrointestinal side effects often associated with non-selective NSAIDs that also inhibit COX-1.

This medication is primarily used for the symptomatic relief of various inflammatory and painful conditions. Its targeted action makes it an effective option for managing chronic pain states and acute inflammatory episodes, providing significant relief from discomfort and improving functional capacity. The 90mg dosage is typically used for conditions requiring stronger anti-inflammatory and analgesic effects.

Uses

• Relief of pain and inflammation in osteoarthritis.
• Management of symptoms in rheumatoid arthritis.
• Treatment of ankylosing spondylitis.
• Alleviation of acute gouty arthritis pain.

Directions For Use

Take one tablet daily, preferably with or after food to reduce stomach upset, or as directed by your doctor. Do not exceed the prescribed dose.

Benefits

• Provides potent pain relief.
• Effectively reduces inflammation.
• Targets specific pain pathways.
• May have a lower risk of gastrointestinal side effects compared to non-selective NSAIDs.
• Improves joint function and mobility.
• Convenient once-daily dosing for many conditions.

Side Effects

• Abdominal pain
• Nausea
• Diarrhea
• Indigestion
• Headache
• Dizziness
• Fatigue
• Peripheral edema (swelling)
• Hypertension (high blood pressure)
• Heartburn
• Flu-like symptoms
• Palpitations

Safety Measures

• Alcohol - Alcohol consumption while taking Etoricoxib can increase the risk of gastrointestinal irritation and bleeding. It is best to avoid or limit alcohol intake.
• Pregnancy - Etoricoxib is not recommended during pregnancy, especially during the third trimester, due to potential adverse effects on fetal cardiovascular development. Consult your doctor before use.
• Breastfeeding - Etoricoxib may be excreted in breast milk. It is generally advised to avoid this medication during breastfeeding or to seek medical advice regarding its use.
• Liver - Patients with moderate to severe liver impairment should use Etoricoxib with caution, and dose adjustments may be necessary. Regular monitoring of liver function is important.
• Kidney - Use with caution in patients with pre-existing kidney disease as NSAIDs can cause dose-dependent renal toxicity. Close monitoring of renal function is recommended.
• Lung - Etoricoxib, like other NSAIDs, can trigger bronchospasm in some asthmatic patients, particularly those sensitive to aspirin. Use with caution in individuals with asthma.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.